secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0000950170-23-062234
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo enters warrant inducement to raise up to $3.4M, issues new warrants at $0.233
--------------------------------------------------------------------------------

- Existing warrant holders agree to exercise up to 16,013,034 shares at $0.233 per share for up to ~$3.4M gross proceeds.
- New Series A and B warrants issued for 200% of exercised shares, with exercise price $0.233; 50% immediately exercisable.
- Proceeds to fund clinical development and working capital; A.G.P./Alliance Global Partners serves as financial advisor (7% fee).
- New warrants subject to beneficial ownership limitations (4.99% or 9.99%); registration statement for resale to be filed by Nov 27, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017023062234/0000950170-23-062234-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017023062234/apvo-20231109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-062234

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer